Small Pharma is followed by the analysts listed below. Please note that any opinions, estimates or forecasts regarding Small Pharma’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Small Pharma or its management. Small Pharma does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
A pipeline of short acting psychedelic programs
Our pipeline targets the development of treatments that provide fast-acting and long-lasting relief, and have in-clinic scalability potential to address the growing mental health crisis.
Years of R&D development
Number of granted patents
CAD$ raised in 2021